Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV

Clinical trial NCT00615758 · COMPLETED

Trial details

NCT number: NCT00615758
Sponsor: Hellenic Oncology Research Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2006-10-01
Primary completion: 2009-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.